Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLIOSTELLA: L19TNF in Combination With Lomustine in Glioblastoma
NCT06336291Phase 2Active, not recruiting
- Sponsor
- Philogen
- Start
- May 2024
- Primary completion
- Jun 2026
- Modality
- Antibody Fragments, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of onfekafusp alfa in glioblastoma (GBM), sponsored by Philogen. Started May 2024; status: active, not recruiting.
02
Drugs
onfekafusp alfa
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT06336291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06336291.